Cite
HARVARD Citation
Barclay, S. et al. (n.d.). PTU-105 Real world effectiveness, safety and cost per cure in hepatitis C patients treated with protease inibitor based therapy: results from the HCV research UK cohort. Gut. pp. A107-A108. [Online].